Prasterone (Intrarosa) is the only FDA-approved intravaginal DHEA insert for dyspareunia caused by vulvovaginal atrophy. Learn how it compares to estradiol patches, pills, gels, and sprays for menopause symptom relief.
Can vaginal progesterone protect the uterus during estrogen HRT? See what trials show, why products differ, and where dosing evidence falls short.
Surgical menopause occurs when the ovaries are removed during surgery, causing an abrupt estrogen drop with more severe symptoms than natural menopause. This guide covers diagnosis, HRT options, hot flashes, vaginal dryness (GSM), and long-term risks.
Tibolone is not FDA-approved in the US. Review what studies show on vaginal atrophy, sexual function and breast cancer risk.
Evidence-based dosing reference for vaginal estrogen (cream, ring, tablet, suppository), plus estradiol patch, oral estradiol, progesterone, and testosterone cream dosing for women. Reviewed by HealthRX.com physicians.
A guide to venous thromboembolism and stroke risk with hormone replacement therapy, covering oral vs. transdermal estrogen, progestogen choice, breast cancer risk, dementia, and gallbladder disease, with trial-level citations.
A guide to women's hormone replacement therapy covering types, benefits, risks, dosing, timing, and what current guidelines and trial evidence support.
No menopause-specific trial is reviewed here. A Mediterranean diet lowered C-reactive protein and interleukin-6 in adults at high cardiovascular risk.
Menopause anxiety and hot flashes share overlapping brain circuits. Learn how the stress-thermostat connection works, what the clinical evidence says about HRT, and when to add non-hormonal options.
Learn how oral micronized progesterone taken at bedtime may improve sleep quality during menopause, what the clinical evidence shows, dosing details, and who should avoid it.
Yes, pregnancy is possible during perimenopause. Learn how fertility changes, what contraception options work, and when you can safely stop using birth control.
A board-reviewed deep look at whether topical estrogen creams, gels, and vaginal preparations flare rosacea, what the evidence says, and how to manage HRT safely if you have rosacea-prone skin.
Learn how growing food at home shifts eating patterns toward higher fiber, diverse phytonutrients, and fermentation-ready produce, all of which feed beneficial gut bacteria and support a healthier microbiome.
A deep dive into the mechanisms by which estrogen maintains collagen density, skin thickness, barrier function, and moisture retention, with trial data, doses, and practical guidance.
Protein reduces cravings for low-nutrient foods by modulating hunger hormones, slowing gastric emptying, and increasing satiety signals. Learn the clinical mechanisms, optimal doses, and practical strategies backed by trial data.
Vaginal estrogen rebuilds the urogenital tissue that recurrent UTIs depend on. Learn the mechanisms, evidence, dosing options, and clinical guidelines behind this underused therapy.
Hot flashes can last anywhere from 6 months to more than 10 years. Learn what the research says about duration, triggers, treatment timelines, and when to call your doctor.
A complete clinical guide to how long menopause lasts, covering perimenopause, menopause, and postmenopause with real durations, symptom timelines, and evidence-based management options.
Perimenopause lasts about 4 years on average and can last up to 10 years. Learn the signs it is ending and when you officially reach menopause.
Perimenopause lasts about four years on average and can last up to 10 years. Learn how STRAW+10 stages the transition and how long symptoms last.
One trial tested 1 g of synthetic conjugated estrogens cream twice weekly for up to 12 weeks. This covers its results and what it did not test.
A step-by-step guide to getting bioidentical hormone replacement therapy (BHRT) online, from choosing a provider to receiving your first prescription and monitoring your progress safely.
Compares human skin-collagen studies of estrogen therapy, tretinoin, collagen peptides and sunscreen in menopause, and how strong each study is.
Learn the fast, evidence-based methods to tell whether a dumbbell, barbell, or machine weight is challenging enough to drive strength and muscle gains. Includes rep-based tests, RPE scales, and clinical loading guidelines.
A complete clinical guide for women on how to test for metabolic syndrome, covering diagnostic criteria, lab panels, waist measurement, and next steps after diagnosis.
A practical guide to evaluating bioidentical hormone therapy clinics for women. Learn what credentials, testing protocols, compounding standards, and red flags to check before starting treatment.
Diarrhea is not on the MedlinePlus list of menopause symptoms. Menopause medicines such as Veozah and Lynkuet, and IBS, are documented causes.
A guide to the best foods that reduce hot flash frequency and severity during menopause, with specific evidence from named trials, real doses, and actionable dietary advice.
A guide to the major causes of low estrogen in women, from menopause and premature ovarian insufficiency to hypothalamic suppression, medications, and chronic illness, with an evidence boundary and a diagnostic decision framework.
Estradiol is abbreviated E2, the primary estrogen made by the ovaries. See normal ranges by cycle phase and menopause, plus its role in bone and heart health.
A food guide covering the exact nutrients, foods, and eating patterns perimenopause demands, with dosing specifics, trial data, and practical meal strategies.
Thirst is not a listed menopause symptom. Hot flashes and night sweats involve sweating, last a median of 7.4 years, and have treatments.
Estrogen drops at menopause and bone resorption outpaces formation for years. Learn the biology, the numbers, and what HRT and other treatments can do to slow skeletal decline.
A deep dive into estrogen's roles in bone health, cardiovascular function, brain chemistry, metabolism, and menopause management, with dosing data and guideline citations.
Your mother's menopause experience is a real clue about yours, but genetics is only part of the picture. Learn which symptoms, timing, and severity factors you actually inherit, and which ones you can change.
Hot flashes affect up to 80% of women during menopause, yet they remain undertreated and misunderstood. This guide examines the biology behind vasomotor symptoms, the cultural gap in how they are taken seriously, and how Alloy menopause treatment approaches hormone therapy for lasting relief.
Irritability is a listed menopause symptom. See what the research shows about mood in perimenopause and which treatments have evidence for hot flashes.
A cautious, evidence-graded look at perimenopause supplements: what has real randomized-trial support, what is plausible but unproven, and what to skip.
Thirst is not a recognized core menopause symptom, but hot flashes and night sweats can cause sweating. See how long they last and what reduces them.
Alcohol can worsen menopause hot flashes and sleep trouble, which may make the morning after harder. See what is documented and what helps.
Hormone fluctuations affect nearly every woman at some point. Learn why these changes are biologically normal, what the science says, and how speaking openly about them, the way Drew Barrymore has, can lead to earlier diagnosis and better care.
Burning mouth syndrome causes a chronic burning, scalding, or tingling sensation on the tongue, lips, or palate. Learn what triggers it, how hormones play a role, and which treatments actually reduce symptoms.
A guide to bupropion for SSRI-induced sexual dysfunction, plus evidence on flibanserin, bremelanotide, vaginal estradiol, and vaginal DHEA (prasterone) for women's sexual health.
Evidence-based review of testosterone therapy for low libido in women, including HSDD diagnosis, trial data from APHRODITE and ADORE, FDA-approved alternatives, and clinical dosing guidance.
A guide explaining how estrogen, progesterone, and testosterone-based HRT affect female libido, what the clinical evidence shows, and when FDA-approved or off-label treatments are appropriate.
A guide to HSDD in women: diagnostic criteria, FDA-approved treatments including flibanserin and bremelanotide, off-label hormonal options, and how related conditions like GSM, vaginismus, and dyspareunia affect sexual desire.
A guide to ospemifene (Osphena) for dyspareunia and vaginal atrophy, with dosing, safety data, head-to-head comparisons with vaginal estradiol, prasterone, flibanserin, and bremelanotide, and a decision framework for choosing the right therapy.
A guide to sexual changes after hysterectomy, covering libido shifts, orgasm changes, genitourinary syndrome of menopause, vaginismus, HSDD, and evidence-based treatment options.
A guide to post-SSRI sexual dysfunction in women, covering PSSD mechanisms, HSDD, female orgasmic disorder, GSM overlap, vaginismus, and evidence-based treatments including flibanserin, bupropion, PT-141, and hormone therapy.
Prasterone and vaginal estradiol for genitourinary syndrome of menopause: mechanism, the cream label, and endometrial and cardiovascular safety data.
Bremelanotide (PT-141, Vyleesi) caused nausea in 40% of women in phase 3 trials, and focal skin darkening in 1% at up to 8 doses a month.
Trazodone is not FDA-approved for sexual problems in women. See what its label says and what one 2019 review lists for sexual dysfunction.
A clinical deep-dive into how tirzepatide (Zepbound) affects bone mineral density, fracture risk, and bone turnover markers, with primary-literature citations and practical monitoring guidance.
A deep dive into tirzepatide's effects on cognition, brain inflammation, and neurological markers, with primary-literature citations and clinical guidance.
No dose adjustment is needed for Zepbound in mild, moderate, or severe liver impairment. Standard titration from 2.5 mg weekly still applies, per PK study data.
A clinician-level breakdown of Zepbound (tirzepatide) pharmacokinetics, covering absorption after subcutaneous injection, protein binding, metabolic pathways, half-life, and renal/hepatic excretion, with citations to FDA labeling, SURMOUNT-1, and primary PK studies.
A guide to switching between Zepbound (tirzepatide) and other weight-loss medications in the same class, including semaglutide, liraglutide, and oral GLP-1 agents. Covers mechanism, dosing bridging strategies, and clinical evidence.
A complete clinical guide to monitoring tirzepatide (Zepbound) in young adults aged 18, 29, covering labs, vitals, fertility, mental health, and dose-escalation checkpoints.
A clinician-oriented review of how Zepbound (tirzepatide) affects appetite, food cravings, and eating behavior, with attention to what is established by trial evidence versus what remains mechanistic hypothesis.
A guide to using Zepbound (tirzepatide) in patients with autoimmune disease, covering immunologic mechanisms, disease-specific risks, drug interactions, and monitoring questions clinicians should raise before prescribing.